MEKK1/MEKK4 are responsible for TRAIL-induced JNK/p38 phosphorylation

Oncology Reports

Volumn 25, Issue 2, 2011, Pages 537-544

  Sun, Bo K ^a   Kim, Joo Hang ^a,b   Nguyen, Hoan N ^a   Oh, Seeun ^a,b   Kim, So Y ^a,b   Choi, Sujin ^a   Choi, Hye J ^a,b   Lee, Yong J ^c   Song, Jae J ^a  

^a Yonsei University College of Medicine   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

14 3 3; c Jun NH2 terminal kinase; Mitogen activated protein kinase kinase 1 4; p38; Tumor necrosis factor related apoptosis inducing ligand

Indexed keywords

APOPTOSIS SIGNAL REGULATING KINASE 1; CASPASE 8; CASPASE 8 INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE KINASE KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE KINASE KINASE 4; MITOGEN ACTIVATED PROTEIN KINASE P38; REACTIVE OXYGEN METABOLITE; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

ARTICLE; CATALYSIS; DRUG ACTIVITY; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN INTERACTION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

14-3-3 PROTEINS; ANTIBODIES; CELL LINE, TUMOR; ENZYME ACTIVATION; HUMANS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MAP KINASE KINASE 4; MAP KINASE KINASE KINASE 1; MAP KINASE KINASE KINASE 4; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PROTEIN BINDING; RNA, SMALL INTERFERING; TNF-RELATED APOPTOSIS-INDUCING LIGAND;

EID: 78651356005     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2010.1079     Document Type: Article

References (36)

1. Wiley SR, Schooley K, Smolak PJ, et al: Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity 3: 673-682, 1995. (Pubitemid 26091143)
2. Pitti RM, Marsters SA, Ruppert S, Donahue CJ, Moore A and Ashkenazi A: Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family. J Biol Chem 271: 12687-12690, 1996. (Pubitemid 26175834)
3. Peter ME, Krammer PH: The CD95(APO-1/Fas) DISC and beyond. Cell Death Differ 10: 26-35, 2003.
4. Kelley SK and Ashkenazi A: Targeting death receptors in cancer with Apo2L/TRAIL. Curr Opin Pharmacol 4: 333-339, 2004. (Pubitemid 38987058)
5. Falschlehner C, Emmerich CH, Gerlach B and Walczak H: TRAIL signalling: Decisions between life and death. Int J Biochem Cell Biol 39: 1462-1475, 2007. (Pubitemid 47031030)
6. Walczak H, Miller RE, Ariail K, et al: Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo. Nat Med 5: 157-163, 1999. (Pubitemid 29068521)
7. Zhu H, Zhang L, Huang X, Davis JJ, Jacob DA, Teraishi F, Chiao P and Fang B: Overcoming acquired resistance to TRAIL by chemotherapeutic agents and calpain inhibitor I through distinct mechanisms. Mol Ther 9: 666-673, 2004.
8. Song JJ, An JY, Kwon YT and Lee YJ: Evidence for two modes of development of acquired TRAIL resistance: Involvement of Bcl-xL. J Biol Chem 282: 319-328, 2007.
9. Song JJ, Kim JH, Sun BK, Alcala Jr MA, Bartlett DL and Lee YJ: c-Cbl acts as a mediator of Src-induced activation of the PI3K-Akt signal transduction pathway during TRAIL treatment. Cell Signal 22: 377-385, 2010.
10. MacFarlane M, Cohen GM and Dickens M: JNK (c-Jun N-terminal kinase) and p38 activation in receptor-mediated and chemically-induced apoptosis of T-cells: differential requirements for caspase activation. Biochem J 15: 93-101, 2000.
11. Varfolomeev E, Maecker H, Sharp D, Lawrence D, Renz M, Vucic D and Ashkenazi A: Molecular determinants of kinase pathway activation by Apo2 ligand/tumor necrosis factor-related apoptosis-inducing ligand. J Biol Chem 280: 40599-40608, 2005.
12. Song JJ and Lee YJ: Differential cleavage of Mst1 by caspase-7/-3 is responsible for TRAIL-induced activation of the MAPK superfamily. Cell Signal 20: 892-906, 2008.
13. Liu ZG, Hsu H, Goeddel DV and Karin M: Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-kappaB activation prevents cell death. Cell 87: 565-576, 1996.
14. Wada T and Penninger JM: Mitogen-activated protein kinases in apoptosis regulation. Oncogene 23: 2838-2849, 2004.
15. Jurewicz A, Matysiak M, Andrzejak S and Selmaj K: TRAIL-induced death of human adult oligodendrocytes is mediated by JNK pathway. Glia 53: 158-166, 2006.
16. Corazza N, Jakob S, Schaer C, Frese S, Keogh A, Stroka D, Kassahn D, Torgler R, Mueller C, Schneider P and Brunner T: TRAIL receptor-mediated JNK activation and Bim phosphorylation critically regulate Fas-mediated liver damage and lethality. J Clin Invest 116: 2493-2499, 2006.
17. Mühlenbeck F, Haas E, Schwenzer R, Schubert G, Grell M, Smith C, Scheurich P and Wajant H: TRAIL/Apo2L activates c-Jun NH2-terminal kinase (JNK) via caspase-dependent and caspase-independent pathways. J Biol Chem 273: 33091-33098, 1998.
18. Jin CY, Park C, Kim GY, Lee SJ, Kim WJ and Choi YH: Genistein enhances TRAIL-induced apoptosis through inhibition of p38 MAPK signaling in human hepatocellular carcinoma Hep3B cells. Chem Biol Interact 180: 143-150, 2009.
19. Zhang L, Zhu H, Davis JJ, Jacob D, Wu S, Teraishi F, Gutierrez A, Wang Y and Fang B: Lack of p38 MAP kinase activation in TRAIL-resistant cells is not related to the resistance to TRAIL-mediated cell death. Cancer Biol Ther 3: 296-301, 2004.
20. Lee MW, Park SC, Yang YG, Yim SO, Chae HS, Bach JH, Lee HJ, Kim KY, Lee WB and Kim SS: The involvement of reactive oxygen species (ROS) and p38 mitogen-activated protein (MAP) kinase in TRAIL/Apo2L-induced apoptosis. FEBS Lett 512: 313-318, 2002.
21. Enomoto A, Kido N, Ito M, Morita A, Matsumoto Y, Takamatsu N, Hosoi Y and Miyagawa K: Negative regulation of MEKK1/2 signaling by serine-threonine kinase 38 (STK38). Oncogene 27: 1930-1938, 2008.
22. Davis RJ: Signal transduction by the JNK group of MAP kinases. Cell 103: 239-252, 2000.
23. Yuasa T, Ohno S, Kehrl JH and Kyriakis JM: Tumor necrosis factor signaling to stress-activated protein kinase (SAPK)/Jun NH2-terminal kinase (JNK) and p38. Germinal center kinase couples TRAF2 to mitogen-activated protein kinase/ERK kinase kinase 1 and SAPK while receptor interacting protein associates with a mitogen-activated protein kinase kinase kinase upstream of MKK6 and p38. J Biol Chem 273: 22681-22692, 1998.
24. Widmann C, Gerwins P, Johnson NL, Jarpe MB and Johnson GL: MEK kinase 1, a substrate for DEVD-directed caspases, is involved in genotoxin-induced apoptosis. Mol Cell Biol 18: 2416-2429, 1998. (Pubitemid 28152687)
25. Aitken A, Collinge DB, van Heusden BP, Isobe T, Roseboom PH, Rosenfeld G and Soll J: 14-3-3 proteins: a highly conserved, widespread family of eukaryotic proteins. Trends Biochem Sci 17: 498-501, 1992.
26. Masters SC, Subramanian RR, Truong A, Yang H, Fujii K, Zhang H and Fu H: Survival-promoting functions of 14-3-3 proteins. Biochem Soc Trans 30: 360-365, 2002.
27. Porter GW, Khuri FR and Fu H: Dynamic 14-3-3/client protein interactions integrate survival and apoptotic pathways. Semin Cancer Biol 16: 193-202, 2006.
28. Abell AN, Granger DA and Johnson GL: MEKK4 stimulation of p38 and JNK activity is negatively regulated by GSK3beta. J Biol Chem 282: 30476-30484, 2007.
29. Song JJ and Lee YJ: Differential activation of the JNK signal pathway by UV irradiation and glucose deprivation. Cell Signal 19: 563-572, 2007.
30. Graves JD, Draves KE, Gotoh Y, Krebs EG and Clark EA: Both phosphorylation and caspase-mediated cleavage contribute to regulation of the Ste20-like protein kinase Mst1 during CD95/Fas-induced apoptosis. J Biol Chem 276: 14909-14915, 2001. (Pubitemid 37373371)
31. Chadee DN, Yuasa T and Kyriakis JM: Direct activation of mitogen-activated protein kinase kinase kinase MEKK1 by the Ste20p homologue GCK and the adapter protein TRAF2. Mol Cell Biol 22: 737-749, 2002. (Pubitemid 34053054)
32. Souza PM and Lindsay MA: Mammalian sterile20-like kinase 1 and the regulation of apoptosis. Biochem Soc Trans 32: 485-488, 2004. (Pubitemid 38813544)
33. Lu Y, Cai Z, Galson DL, Xiao G, Liu Y, George DE, Melhem MF, Yao Z and Zhang J: Monocyte chemotactic protein-1 (MCP-1) acts as a paracrine and autocrine factor for prostate cancer growth and invasion. Prostate 66: 1311-1318, 2006. (Pubitemid 44384308)
34. Lu Y, Cai Z, Xiao G, Keller ET, Mizokami A, Yao Z, Roodman GD and Zhang J: Monocyte chemotactic protein-1 mediates prostate cancer-induced bone resorption. Cancer Res 67: 3646-3653, 2007. (Pubitemid 46762149)
35. Shtievelman E: A link between metastasis and resistance to apoptosis of variant small cell lung carcinoma. Oncogene 14: 2167-2173, 1997. (Pubitemid 27248228)
36. Takaoka A, Adachi M, Okuda H, Sato S, Yawata A, Hinoda Y, Takayama S, Reed JC and Imai K: Anti-cell death activity promotes pulmonary metastasis of melanoma cells. Oncogene 14: 2971-2977, 1997. (Pubitemid 27315666)